sever
pneumonia
common
caus
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
set
prompt
initi
antibiot
recommend
howev
bacteri
etiolog
found
approxim
case
pathogen
respiratori
virus
report
sever
aecopd
requir
ventil
pneumon
aecopd
moreov
clinic
practic
sign
symptom
bacteri
viral
lower
respiratori
tract
infect
wide
overlap
procalcitonin
pct
describ
marker
bacteri
infect
thu
may
help
physician
limit
inadequ
use
antibiot
previous
investig
use
pct
patient
aecopd
without
pneumonia
hospit
icu
studi
assess
pct
level
overtim
relationship
bacteri
infect
chronic
obstruct
pulmonari
diseas
copd
patient
admit
icu
sever
pneumonia
addit
examin
whether
pct
threshold
predict
probabl
bacteri
infect
previous
report
could
effici
specif
popul
conduct
monocentr
prospect
cohort
studi
consecut
copd
patient
suspect
lower
respiratori
tract
infect
admit
medic
intens
care
unit
univers
hospit
caen
septemb
septemb
assess
elig
infiltr
present
initi
chest
radiograph
admiss
icu
suspect
acut
communityacquir
pneumonia
includ
defin
copd
accord
global
initi
chronic
obstruct
lung
diseas
guidelin
gold
http
wwwgoldcopdcom
pneumon
aecopd
defin
new
infiltr
chest
radiograph
featur
lower
respiratori
tract
infect
copd
patient
use
pneumonia
sever
index
psi
estim
sever
systemat
search
bacteria
standard
method
virus
sensit
method
ie
pcr
rtpcr
method
report
elsewher
perform
briefli
sputum
tracheal
aspir
bacteriolog
process
less
observ
field
contain
squamou
epitheli
cell
neutrophil
observ
pneumonia
consid
bacteriolog
confirm
least
one
follow
criteria
present
pathogen
concentr
greater
cfuml
tracheobronchi
aspir
sputum
sampl
blood
cultur
posit
bacteri
pathogen
absenc
extrapulmonari
focu
addit
serolog
diagnost
antibodi
legionella
pneumophila
perform
indirect
immunofluoresc
associ
detect
legionella
pneumophila
serogroup
antigen
urin
sampl
patient
ethic
board
decid
approv
necessari
given
observ
natur
studi
accordingli
inform
consent
obtain
patient
baselin
copd
sever
accord
gold
criteria
comorbid
clinic
biolog
variabl
record
patient
treat
accord
recommend
french
consensu
confer
ie
antibiot
treatment
recommend
sever
pneumonia
sever
exacerb
copd
patient
requir
admiss
icu
procalcitonin
pct
assess
follow
standard
method
describ
elsewher
circul
level
pct
sequenti
assess
icu
admiss
six
hour
twenti
four
hour
icu
blood
sampl
analyz
end
studi
period
pct
measur
use
sensit
immunoassay
kryptor
pct
brahm
hennigsdorf
germani
function
assay
sensit
fourfold
mean
normal
level
patient
classifi
three
group
base
probabl
bacteri
infect
accord
highest
procalcitonin
level
measur
pctmax
previous
report
group
group
pctmax
indic
low
probabl
bacteri
infect
group
pctmax
indic
unlik
possibl
bacteri
infect
infect
group
pctmax
indic
high
probabl
bacteri
infect
quantit
qualit
data
express
mean
sd
median
interquartil
rang
iqr
percentag
confid
interv
ci
base
normal
approxim
respect
categor
variabl
compar
use
chisquar
fischer
exact
test
appropri
quantit
variabl
compar
use
student
ttest
mannwhitney
non
parametr
test
appropri
level
signific
set
test
twosid
use
epiinfo
version
dfr
epiinfo
cdc
atlanta
ga
data
collect
epiinfo
sa
version
sa
institut
inc
cari
nc
data
analysi
studi
period
copd
patient
suspect
lower
respiratori
tract
infect
admit
icu
pneumonia
baselin
characterist
pneumon
aecopd
patient
shown
tabl
twenti
three
patient
sever
sever
copd
previou
period
antibiot
oral
steroid
therapi
exacerb
copd
report
patient
respect
eleven
patient
receiv
antibiot
within
hour
preced
icu
admiss
except
patient
sever
pneumonia
psi
class
iv
v
patient
requir
ventil
support
non
invas
ventil
niv
patient
invas
mechan
ventil
patient
receiv
invas
mechan
ventil
niv
failur
patient
receiv
antibiot
inhal
steroid
system
steroid
mean
length
icu
stay
day
mean
length
noninvas
ventil
invas
mechan
ventil
ventilationfre
day
icu
stay
day
day
day
respect
fourteen
patient
develop
septic
shock
nine
first
hour
follow
icu
admiss
five
icu
stay
six
patient
develop
ventilatorassoci
pneumonia
twenti
two
patient
discharg
hospit
twelv
patient
die
eight
septic
shock
three
copdrel
respiratori
failur
one
malign
bronchospasm
complic
cardiac
arrest
median
iqr
pct
level
follow
admiss
pct
level
differ
patient
receiv
antibiot
within
month
hour
prior
icu
admiss
compar
antibioticna
patient
vs
p
vs
p
respect
addit
steroid
prior
icu
admiss
influenc
pct
level
p
significantli
higher
abnorm
breath
sound
rale
present
vs
p
fever
present
vs
p
associ
found
level
presenc
absenc
sputum
cough
pctmax
patient
patient
patient
includ
patient
pctmax
associ
pctmax
level
sever
copd
p
simplifi
acut
physiolog
score
type
ii
sapsii
p
logist
organ
dysfonct
lod
p
psi
p
figur
depict
bacteri
find
accord
pctmax
level
dynam
pct
measur
bacteri
find
shown
figur
fifteen
patient
microbiologicallyconfirm
pneumonia
fifteen
bacteria
pseudomona
aeruginosa
haemophilu
influenza
streptoccocu
speci
methicillinresist
staphyloccocu
aureu
serratia
speci
fusibacterium
nucleatum
virus
rhinoviru
human
metapneumoviru
respiratori
synciti
viru
detect
coinfect
detect
case
rhinoviru
streptoccocu
rhinoviru
haemophilu
influenza
rhinoviru
fusibacterium
nucleatum
seven
patient
cross
pct
group
time
figur
bacteria
detect
patient
pctmax
level
contrast
bacteria
detect
half
patient
estim
unlik
bacteri
infect
pctmax
studi
examin
microbiolog
find
pct
level
critic
ill
copd
patient
admit
pneumonia
knowledg
address
specif
set
icu
agreement
previou
report
pct
level
could
indic
low
probabl
bacteri
infect
approxim
patient
contrast
bacteria
detect
half
patient
pct
level
suggest
unlik
possibl
bacteri
infect
pctmax
previous
defin
outsid
icu
therefor
pct
cut
antibiot
use
may
appropri
sever
pneumonia
patient
copd
admit
icu
found
median
pct
level
copd
patient
admit
icu
pneumonia
find
consist
previou
studi
focus
communityacquir
pneumonia
cap
howev
two
larg
prospect
cohort
focus
cap
less
patient
copd
less
admit
icu
previou
report
pct
level
differ
patient
pretreat
antibiot
antibioticna
patient
find
confirm
studi
contrast
previou
report
found
associ
pct
level
clinic
symptom
fever
abnorm
breath
sound
rale
distribut
patient
accord
pctmax
level
ie
similar
previous
report
christcrain
et
al
patient
pctmax
level
bacteria
detect
suggest
antibiot
may
unnecessari
subgroup
contrast
bacteria
detect
half
patient
pct
level
suggest
unlik
possibl
bacteri
infect
pctmax
result
suggest
pct
level
cutoff
rather
propos
non
sever
pneumonia
may
appropri
initi
antibiot
pct
base
antibiot
strategi
critic
ill
copd
patient
pneumonia
studi
howev
remain
conduct
addit
studi
confirm
import
sequenti
pct
level
assess
predict
probabl
bacteri
infect
specif
first
measur
low
ie
pct
inde
three
five
patient
cross
pct
group
pct
group
time
bacteriolog
document
pneumonia
point
import
implic
further
studi
assess
procalcitoninbas
antibiot
strategi
set
awar
limit
studi
includ
monocentr
design
small
sampl
size
addit
prior
icu
admiss
antibiot
treatment
subset
patient
may
affect
result
microbiolog
examin
howev
patient
pretreat
antibiot
pct
level
higher
except
two
pct
group
indic
high
probabl
presenc
bacteri
infect
strength
studi
includ
dynam
measur
pct
along
systemat
search
bacteria
specif
popul
reason
believ
studi
add
use
inform
pct
level
copd
patient
sever
pneumonia
requir
admiss
icu
likelihood
bacteri
infect
studi
report
less
copd
patient
suspect
sever
pneumonia
pct
level
lower
suggest
low
probabl
bacteri
infect
subset
patient
pct
level
rang
previous
report
indic
unlik
possibl
bacteri
infect
document
bacteri
infect
base
result
hypothes
pct
level
cut
may
appropri
previous
propos
non
sever
lower
respiratori
tract
infect
predict
probabl
bacteri
infect
sever
copd
patient
pneumonia
procalcitoninbas
antibiot
strategi
howev
clinic
practic
procalcitoninbas
antibiot
strategi
use
pct
threshold
limit
impact
decis
initi
antibiot
set
studi
necessari
assess
capabl
procalcitonin
guidanc
shorten
antibiot
durat
critic
ill
copd
patient
pneumonia
aecopd
acut
exacerb
chronic
obstruct
pulmonari
diseas
apach
ii
acut
physiolog
chronic
health
evalu
type
ii
icu
medic
intens
care
unit
lod
logist
organ
dysfunct
system
pcr
polymeras
chain
reaction
psi
pneumonia
sever
index
sap
ii
simplifi
acut
physiolog
score
ii
author
declar
compet
interest
cd
mr
initi
studi
design
experiment
protocol
sf
perform
pct
measur
av
ff
perform
virolog
assess
cd
jjp
perform
statist
analysi
involv
interpret
result
cd
wrote
manuscript
jjp
mr
ddc
help
draft
manuscript
ddc
mr
nt
pc
contribut
concept
design
studi
revis
manuscript
author
read
approv
final
manuscript
prepubl
histori
paper
access
http
